NCT01989468 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01988103 Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis Status COMPLETED Phase PHASE2
NCT01965132 Korean College of Rheumatology Biologics and Targeted Therapy Registry Status RECRUITING Phase N/A
NCT01939132 Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis Status UNKNOWN Phase PHASE4
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions Status COMPLETED Phase N/A
NCT01925768 Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01901185 Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept Status COMPLETED Phase PHASE3
NCT01892436 Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01891903 to Translate and Validate the TOPAS TORONTO PSORIATIC SCREENING QUESTIONNAIRE)Into Spanish Status UNKNOWN Phase N/A
NCT01882439 Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors Status COMPLETED Phase PHASE3
NCT01877668 Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study Status COMPLETED Phase PHASE3
NCT01860976 Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01845818 Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium Status COMPLETED Phase N/A
NCT01833468 Functional Limitations Due To The Foot Involvement In Spondyloarthritis Status COMPLETED Phase N/A
NCT01818804 The Effect of n-3 Polyunsaturated Fatty Acids in Patients With Psoriatic Arthritis Status COMPLETED Phase NA
NCT01768858 Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice Status COMPLETED Phase N/A
NCT01752634 Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis Status COMPLETED Phase PHASE3